Astrazeneca (AZN) Dividends Paid - Common (2009 - 2026)

Astrazeneca has reported Dividends Paid - Common for 18 years, with the latest figure at -$1.0 million in Q2 2026.

• On a quarterly basis, Dividends Paid - Common rose 90.0% year-over-year to -$1.0 million in Q2 2026; TTM through Jun 2026 was -$4.9 billion, a 0.69% increase from a year earlier, with the FY2025 full-year figure at -$5.0 billion, down 7.39% from the prior year.
• Dividends Paid - Common was -$1.0 million for Q2 2026 at Astrazeneca, up from -$3.3 billion in the prior quarter.
• The five-year high for Dividends Paid - Common was -$1.0 million in Q2 2026, with the low at -$3.3 billion in Q1 2025.
• Average Dividends Paid - Common over 5 years is -$1.5 billion, with a median of -$1.6 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Dividends Paid - Common retreated 20.33% in 2022, then surged 90.0% in 2026.
• Over 5 years, Dividends Paid - Common stood at -$3.0 billion in 2022, then jumped by 99.26% to -$22.0 million in 2023, then soared by 86.36% to -$3.0 million in 2024, then changed by 0.0% to -$3.0 million in 2025, then surged by 66.67% to -$1.0 million in 2026.
• The last three Dividends Paid - Common figures came in at -$1.0 million (Q2 2026), -$3.3 billion (Q1 2026), and -$3.0 million (Q4 2025), per Business Quant data.